In Patient 1, who had a chemotherapy-naïve tumor, NGS revealed pathogenic mutations in CTNNB1 and STK11. The CTNNB1 gene encodes β-catenin, a key component of the Wnt signaling pathway [18]. The gene discussed is CTNNB1; the disease is neoplasm.